Literature DB >> 15993703

Toll-like receptors and their role in the trophoblast.

V M Abrahams1, G Mor.   

Abstract

The aim of this review is to discuss the role of Toll-like receptors at the maternal-fetal interface and the capacity of trophoblast cells to initiate innate immune responses towards infection. The maternal-fetal interface represents an immunologically unique site that must promote tolerance to the allogenic fetus, whilst maintaining host defense against a diverse array of possible pathogens. Clinical studies have shown a strong association between certain complications of pregnancy and intrauterine infections. Therefore, innate immune responses against microorganisms at the maternal-fetal interface may have a significant impact on the success of a pregnancy. There is growing evidence that trophoblast cells are able to recognize and respond to pathogens through the expression of Toll-like receptors, an important part of innate immunity. This review will discuss the role of Toll-like receptors at the maternal-fetal interface, the potential for trophoblast cells to function as components of the innate immune system and the impact TLR-mediated trophoblast responses may have on pregnancy outcome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15993703     DOI: 10.1016/j.placenta.2004.08.010

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  49 in total

Review 1.  Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis.

Authors:  Ronald F Lamont; Chia-Ling Nhan-Chang; Jack D Sobel; Kimberly Workowski; Agustin Conde-Agudelo; Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2011-04-02       Impact factor: 8.661

2.  Murine fetoplacental infection models.

Authors:  Raymond W Redline; Yiping W Han; Christopher Y Lu; Lakshmi Krishnan
Journal:  Infect Immun       Date:  2010-11       Impact factor: 3.441

3.  Cell type-specific expression and function of toll-like receptors 2 and 4 in human placenta: implications in fetal infection.

Authors:  Y Ma; G Krikun; V M Abrahams; G Mor; S Guller
Journal:  Placenta       Date:  2007-06-22       Impact factor: 3.481

4.  Chlamydia trachomatis infection modulates trophoblast cytokine/chemokine production.

Authors:  Eugenia de la Torre; Melissa J Mulla; Andrew G Yu; Seung-Joon Lee; Paula B Kavathas; Vikki M Abrahams
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

Review 5.  A review of the fetal brain cytokine imbalance hypothesis of schizophrenia.

Authors:  Urs Meyer; Joram Feldon; Benjamin K Yee
Journal:  Schizophr Bull       Date:  2008-04-11       Impact factor: 9.306

6.  Adaptive history of single copy genes highly expressed in the term human placenta.

Authors:  Zhuocheng Hou; Roberto Romero; Monica Uddin; Nandor Gabor Than; Derek E Wildman
Journal:  Genomics       Date:  2008-11-05       Impact factor: 5.736

Review 7.  Toll-like receptors in pregnancy disorders and placental dysfunction.

Authors:  Joan K Riley; D Michael Nelson
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

8.  The unique immunological and microbial aspects of pregnancy.

Authors:  Gil Mor; Paulomi Aldo; Ayesha B Alvero
Journal:  Nat Rev Immunol       Date:  2017-06-19       Impact factor: 53.106

9.  Endoglin in amniotic fluid as a risk factor for the subsequent development of bronchopulmonary dysplasia.

Authors:  Sun K Kim; Roberto Romero; Zeynep A Savasan; Yi Xu; Zhong Dong; Deug-Chan Lee; Lami Yeo; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  Am J Reprod Immunol       Date:  2012-12-24       Impact factor: 3.886

10.  MyD88 and TRIF mediate the cyclic adenosine monophosphate (cAMP) induced corticotropin releasing hormone (CRH) expression in JEG3 choriocarcinoma cell line.

Authors:  Andy Uh; Charles F Simmons; Catherine Bresee; Nasif Khoury; Adrian F Gombart; Richard C Nicholson; Hande Kocak; Ozlem Equils
Journal:  Reprod Biol Endocrinol       Date:  2009-07-17       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.